Guardant Health, Inc. (GH)

Guardant Health Statistics

Total Valuation

GH has a market cap or net worth of $3.90 billion. The enterprise value is $4.31 billion.

Market Cap	3.90B
Enterprise Value	4.31B

Important Dates

The last earnings date was Wednesday, November 6, 2024, after market close.

Earnings Date	Nov 6, 2024
Ex-Dividend Date	n/a

Share Statistics

GH has 123.55 million shares outstanding. The number of shares has increased by 12.48% in one year.

Current Share Class	123.55M
Shares Outstanding	123.55M
Shares Change (YoY)	+12.48%
Shares Change (QoQ)	+0.49%
Owned by Insiders (%)	4.57%
Owned by Institutions (%)	91.07%
Float	104.39M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	5.54
Forward PS	4.73
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	6.23
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 6.22

Current Ratio	6.22
Quick Ratio	5.15
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-166.26

Financial Efficiency

Return on equity (ROE) is -609.28% and return on invested capital (ROIC) is -18.72%.

Return on Equity (ROE)	-609.28%
Return on Assets (ROA)	-16.08%
Return on Capital (ROIC)	-18.72%
Revenue Per Employee	$389,126
Profits Per Employee	-$288,033
Employee Count	1,779
Asset Turnover	0.42
Inventory Turnover	3.68

Taxes

In the past 12 months, GH has paid $27,000 in taxes.

Income Tax	27,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +9.81% in the last 52 weeks. The beta is 1.26, so GH's price volatility has been higher than the market average.

Beta (5Y)	1.26
52-Week Price Change	+9.81%
50-Day Moving Average	29.25
200-Day Moving Average	25.95
Relative Strength Index (RSI)	45.40
Average Volume (20 Days)	1,421,618

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, GH had revenue of $692.26 million and -$512.41 million in losses. Loss per share was -$4.22.

Revenue	692.26M
Gross Profit	417.53M
Operating Income	-429.11M
Pretax Income	-490.27M
Net Income	-512.41M
EBITDA	-386.31M
EBIT	-429.11M
Loss Per Share	-$4.22

Balance Sheet

The company has $927.00 million in cash and $1.34 billion in debt, giving a net cash position of -$412.41 million or -$3.34 per share.

Cash & Cash Equivalents	927.00M
Total Debt	1.34B
Net Cash	-412.41M
Net Cash Per Share	-$3.34
Equity (Book Value)	-60.10M
Book Value Per Share	-0.49
Working Capital	1.03B

Cash Flow

In the last 12 months, operating cash flow was -$254.07 million and capital expenditures -$20.29 million, giving a free cash flow of -$274.36 million.

Operating Cash Flow	-254.07M
Capital Expenditures	-20.29M
Free Cash Flow	-274.36M
FCF Per Share	-$2.22

Margins

Gross margin is 60.31%, with operating and profit margins of -61.99% and -74.02%.

Gross Margin	60.31%
Operating Margin	-61.99%
Pretax Margin	-74.02%
Profit Margin	-74.02%
EBITDA Margin	-55.80%
EBIT Margin	-61.99%
FCF Margin	n/a

Dividends & Yields

GH does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-12.48%
Shareholder Yield	-12.48%
Earnings Yield	-13.14%
FCF Yield	-7.03%

Analyst Forecast

The average price target for GH is $39.93, which is 26.48% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$39.93
Price Target Difference	26.48%
Analyst Consensus	Strong Buy
Analyst Count	14
Revenue Growth Forecast (5Y)	24.96%
EPS Growth Forecast (5Y)	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

GH has an Altman Z-Score of -0.78 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-0.78
Piotroski F-Score	3